NoGeneST™ TTR-ASO, Antisense Oligonucleotide

Name: NoGeneST™ TTR-ASO, Antisense Oligonucleotide
SKU: NRYF-0625-XY18
Rating: 5 (1 reviews)

[CAT#: NRYF-0625-XY18]

Target:: TTR

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

Product Overview

Description

TTR-ASO is a 2'-O-methoxyethyl-modified antisense oligonucleotide that inhibits transthyretin (TTR) protein production by targeting and reducing TTR RNA transcript levels.

Species

Human

Applications

Targeting Transthyretin (TTR), our TTR-ASO is pivotal for researching familial amyloid polyneuropathy. It enables precise modulation of TTR expression, allowing researchers to investigate the role of TTR aggregation in nerve fiber degeneration, sensory and motor dysfunction, and to evaluate TTR as a therapeutic target for treating TTR - related neurological diseases.

Relevant Diseases

Peripheral nerve damage

Properties

Appearance

Solid

Shipping

Room temperature

Storage

Store at -20°C, sealed and away from moisture.
In solvent, store at -80°C for up to 6 months, or -20°C for up to 1 month (sealed and away from moisture).